Eye fluid holds clues to saving sight in kids with retinoblastoma

NCT ID NCT04959097

Recruiting now Knowledge-focused Sponsor: Children's Hospital Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects medical information and fluid from the front of the eye (aqueous humor) from up to 800 children with retinoblastoma, a rare eye cancer. Researchers aim to find biological markers in the fluid that can predict whether the eye can be saved with treatment. The study does not test a new treatment but gathers data to improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bilateral retinoblastoma retinoblastoma unilateral retinoblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINOBLASTOMA RETINOBLASTOMA BILATERAL RETINOBLASTOMA UNILATERAL

Contacts and locations

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITING

Chicago, Illinois, 60611, United States
Children's Hospital Los Angeles
RECRUITING

Los Angeles, California, 90027, United States
Emory University Children's Healthcare of ATL
RECRUITING

Atlanta, Georgia, 30322, United States
Oregon Health & Science University: Casey Eye Institute
RECRUITING

Portland, Oregon, 97239, United States
Phoenix Children's Hospital
RECRUITING

Phoenix, Arizona, 85016, United States
Seattle Children's Hospital; University of Washington
RECRUITING

Seattle, Washington, 98101, United States
St. Jude Children's Research Hospital
RECRUITING

Memphis, Tennessee, 38105, United States
The Hospital for Sick Children (Toronto SickKids)
RECRUITING

Toronto, Ontario, M5G 2L3, Canada
Wills Eye Institute
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.